| Autor: |
Tweedie D; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA. donald.tweedie@boehringer-ingelheim.com, Polli JW, Berglund EG, Huang SM, Zhang L, Poirier A, Chu X, Feng B |
| Jazyk: |
angličtina |
| Zdroj: |
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2013 Jul; Vol. 94 (1), pp. 113-25. Date of Electronic Publication: 2013 Apr 10. |
| DOI: |
10.1038/clpt.2013.77 |
| Abstrakt: |
The International Transporter Consortium (ITC) organized a second workshop in March 2012 to expand on the themes developed during the inaugural ITC workshop held in 2008. The final session of the workshop provided perspectives from regulatory and industry-based scientists, with input from academic scientists, and focused primarily on the decision trees published from the first workshop. These decision trees have become a central part of subsequent regulatory drug-drug interaction (DDI) guidances issued over the past few years. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text